Compare · BBLG vs ISRG
BBLG vs ISRG
Side-by-side comparison of Bone Biologics Corp (BBLG) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBLG and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $131.36B, about 78808.5x BBLG ($1.7M).
- Over the past year, BBLG is down 72.9% and ISRG is down 21.6% - ISRG leads by 51.3 points.
- ISRG has been more active in the news (7 items in the past 4 weeks vs 3 for BBLG).
- ISRG has more recent analyst coverage (25 ratings vs 0 for BBLG).
- Company
- Bone Biologics Corp
- Intuitive Surgical Inc.
- Price
- $0.60-0.86%
- $371.73-0.51%
- Market cap
- $1.7M
- $131.36B
- 1M return
- -46.68%
- +4.19%
- 1Y return
- -72.86%
- -21.60%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 3
- 7
- Recent ratings
- 0
- 25
Bone Biologics Corp
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest BBLG
- SEC Form PRE 14A filed by Bone Biologics Corp
- SEC Form 10-Q filed by Bone Biologics Corp
- Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
- SEC Form EFFECT filed by Bone Biologics Corp
- SEC Form 424B3 filed by Bone Biologics Corp
- Bone Biologics Corp filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
- SEC Form DEFA14A filed by Bone Biologics Corp
- SEC Form S-3 filed by Bone Biologics Corp
- Bone Biologics Corp filed SEC Form 8-K: Other Events
Latest ISRG
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $59,439 worth of shares (154 units at $385.97) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 881 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $90,778 worth of shares (231 units at $392.98) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 1,035 units (SEC Form 4)
- Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen
- Director Guthart Gary S sold $4,000,000 worth of shares (10,000 units at $400.00) as part of a pre-agreed trading plan (SEC Form 4)
- Intuitive Surgical upgraded by Oppenheimer with a new price target
- Director Ladd Amy L sold $179,903 worth of shares (472 units at $381.15) as part of a pre-agreed trading plan, decreasing direct ownership by 73% to 179 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $151,600 worth of shares (400 units at $379.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 5,320 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $19,539 worth of shares (56 units at $348.91) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 1,266 units (SEC Form 4)
- Intuitive Surgical downgraded by HSBC Securities with a new price target
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $29,954 worth of shares (84 units at $356.60) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 1,322 units (SEC Form 4)